Baltimore, August 8, 2007 - Avanti NanoSciences signed a MoU with Chungcheongbuk-do of the Republic of Korea to establish a research, development and manufacturing center at Osong Biotechnopolis. The MOU signed between Avanti and Chungcheongbuk-do will upgrade cooperation between the two parties by promoting technology transfer, R & D activities, and bio-product development and commercialization, said Dr. Arkesh Mehta, CEO of Avanti NanoSciences.
